Repligen
RGEN
#2880
Rank
$5.83 B
Marketcap
$103.38
Share price
-3.41%
Change (1 day)
-19.26%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2026 (TTM): $0.92

According to Repligen 's latest financial reports the company's current EPS (TTM) is $0.92. In 2025 the company made an earnings per share (EPS) of $0.87 an increase over its 2024 EPS that were of -$0.51.

EPS history for Repligen from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$0.925.75%
2025$0.87-270.59%
2024-$0.51-168%
2023$0.75-77.68%
2022$3.3643.59%
2021$2.34105.26%
2020$1.14153.33%
2019$0.4518.42%
2018$0.38-47.95%
2017$0.73108.57%
2016$0.3520.69%
2015$0.2916%
2014$0.25-48.98%
2013$0.496.52%
2012$0.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.31 42.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$18.22 1,880.43%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$8.19 790.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$3.56 286.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-$0.44-147.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$2.74 197.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$6.71 629.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.71-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.40 52.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-$2.95-420.65%๐Ÿ‡บ๐Ÿ‡ธ USA